Assenagon Asset Management’s Haemonetics HAE Stock Holding History

Assenagon Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Sell	35,109 -142,292	-80%	-$9.14M	﹤0.01%	799
2026 Q1	$10M	Buy	177,401 +100,910	+132%	+$6.57M	0.02%	460
2025 Q4	$6.13M	Sell	76,491 -99,083	-56%	-$6.66M	0.01%	609
2025 Q3	$8.56M	Buy	+175,574	New	+$10.9M	0.01%	520
2024 Q4	–	Sell	-15,223	Closed	-$1.22M	–	1380
2024 Q3	$1.22M	Sell	15,223 -46,211	-75%	-$3.73M	﹤0.01%	1092
2024 Q2	$5.08M	Buy	61,434 +48,464	+374%	+$4.26M	0.01%	630
2024 Q1	$1.11M	Buy	+12,970	New	+$1.02M	﹤0.01%	1027
2023 Q1	–	Sell	-171,426	Closed	-$13.5M	–	1449
2022 Q4	$13.5M	Sell	171,426 -595	-0.3%	-$47.8K	0.05%	325
2022 Q3	$12.7M	Sell	172,021 -36,737	-18%	-$2.64M	0.05%	299
2022 Q2	$13.6M	Sell	208,758 -64,938	-24%	-$3.84M	0.05%	303
2022 Q1	$17.3M	Buy	273,696 +56,183	+26%	+$3.06M	0.05%	261
2021 Q4	$11.5M	Buy	217,513 +180,207	+483%	+$11M	0.03%	304
2021 Q3	$2.63M	Sell	37,306 -575,474	-94%	-$36.3M	0.01%	613
2021 Q2	$40.8M	Buy	612,780 +478,207	+355%	+$33.8M	0.14%	129
2021 Q1	$14.9M	Buy	134,573 +132,691	+7,051%	+$16.4M	0.06%	259
2020 Q4	$223K	Sell	1,882 -12,776	-87%	-$1.38M	﹤0.01%	946
2020 Q3	$1.28M	Sell	14,658 -165,694	-92%	-$14.5M	0.01%	716
2020 Q2	$16.2M	Buy	+180,352	New	+$18.2M	0.1%	126
2020 Q1	–	Sell	-28,255	Closed	-$3.25M	–	874
2019 Q4	$3.25M	Buy	+28,255	New	+$3.42M	0.02%	310
2019 Q1	–	Sell	-11,368	Closed	-$1.14M	–	1005
2018 Q4	$1.14M	Buy	+11,368	New	+$1.19M	0.01%	613
2018 Q2	–	Sell	-104,218	Closed	-$7.63M	–	506
2018 Q1	$7.63M	Buy	104,218 +37,438	+56%	+$2.57M	0.1%	185
2017 Q4	$3.88M	Buy	+66,780	New	+$3.52M	0.04%	311

Other funds holding HAE

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management's HAE Position: Q2 2026 in Review

Assenagon Asset Management reduced its Haemonetics (HAE) stake by 80% in Q2 2026, selling an estimated $9.14M and leaving 35,109 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Assenagon Asset Management first reported a position in HAE in Q4 2017 and has held it in 22 quarters since. The position peaked at $40.8M in Q2 2021. 31 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Assenagon Asset Management held 35,109 shares of Haemonetics worth $2.63M as of Q2 2026.
Assenagon Asset Management sold 142,292 Haemonetics shares in Q2 2026, an estimated $9.14M.
Haemonetics made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #799 holding.
Assenagon Asset Management first reported a position in Haemonetics in Q4 2017 and has held it in 22 quarters since.
Assenagon Asset Management's Haemonetics position peaked at $40.8M in Q2 2021.
31 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.